Biodegradable collagen patch with covalently immobilized VEGF for myocardial repair

Biomaterials

Volumn 32, Issue 5, 2011, Pages 1280-1290

  Miyagi, Yasuo ^a   Chiu, Loraine L Y ^b   Cimini, Massimo ^a   Weisel, Richard D ^a   Radisic, Milica ^b,c   Li, Ren Ke ^a  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

Angiogenesis; Cardiac tissue engineering; Collagen; Growth factors; Heart; Scaffold

Indexed keywords

ANGIOGENESIS; BONE MARROW CELLS; CARDIAC TISSUE ENGINEERING; CELL SURVIVAL; CELL TRANSFECTION; CLINICAL PRACTICES; COLLAGEN SCAFFOLDS; CONTROLLED RELEASE; COVALENT IMMOBILIZATION; ENGINEERED TISSUES; GROWTH FACTOR; IN-VITRO; IN-VIVO; KEY PROBLEMS; NEOVASCULARIZATION; RAT HEART; RIGHT VENTRICULAR; TISSUE FORMATION; VASCULAR ENDOTHELIAL GROWTH FACTOR; VASCULARIZATION;

BIOMATERIALS; BLOOD VESSELS; CELL IMMOBILIZATION; COLLAGEN; ENDOTHELIAL CELLS; HEART; HISTOLOGY; PEPTIDES; RAT CONTROL; SELF ASSEMBLY; TISSUE; TISSUE ENGINEERING;

SCAFFOLDS;

COLLAGEN; VASCULOTROPIN 165;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD VESSEL WALL; BONE MARROW CELL; CELL GROWTH; CELL METABOLISM; CELL PROLIFERATION; CELL SURVIVAL; ENDOTHELIUM CELL; GENETIC TRANSFECTION; HEART MUSCLE REVASCULARIZATION; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; RAT;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; BIOCOMPATIBLE MATERIALS; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; COLLAGEN; FEMALE; HEART; MICROSCOPY, ELECTRON, SCANNING; MYOCARDIUM; RATS; RATS, SPRAGUE-DAWLEY; RATS, WISTAR; TISSUE ENGINEERING; TISSUE SCAFFOLDS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

RATTUS;

EID: 78649771168     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2010.10.007     Document Type: Article

References (41)

1. Jones R.H., Velazquez E.J., Michler R.E., Sopko G., Oh J.K., O'Connor C.M., et al. Coronary bypass surgery with or without surgical ventricular reconstruction. N Engl J Med 2009, 360:1705-1717.
2. Shin'oka T., Matsumura G., Hibino N., Naito Y., Watanabe M., Konuma T., et al. Midterm clinical result of tissue-engineered vascular autografts seeded with autologous bone marrow cells. J Thorac Cardiovasc Surg 2005, 129:1330-1338.
3. Matsubayashi K., Fedak P.W., Mickle D.A., Weisel R.D., Ozawa T., Li R.K. Improved left ventricular aneurysm repair with bioengineered vascular smooth muscle grafts. Circulation 2003, 108(Suppl. 1):II219-II225.
4. Tucker O.P., Syburra T., Augstburger M., van Melle G., Gebhard S., Bosman F., et al. Small intestine without mucosa as a growing vascular conduit: a porcine experimental study. J Thorac Cardiovasc Surg 2002, 124:1165-1175.
5. Zhao Z.Q., Puskas J.D., Xu D., Wang N.P., Mosunjac M., Guyton R.A., et al. Improvement in cardiac function with small intestine extracellular matrix is associated with recruitment of c-kit cells, myofibroblasts, and macrophages after myocardial infarction. J Am Coll Cardiol 2010, 55:1250-1261.
6. Ott H.C., Matthiesen T.S., Goh S.K., Black L.D., Kren S.M., Netoff T.I., et al. Perfusion-decellularized matrix: using nature's platform to engineer a bioartificial heart. Nat Med 2008, 14:213-221.
7. Caspi O., Lesman A., Basevitch Y., Gepstein A., Arbel G., Habib I.H., et al. Tissue engineering of vascularized cardiac muscle from human embryonic stem cells. Circ Res 2007, 100:263-272.
8. Radisic M., Yang L., Boublik J., Cohen R.J., Langer R., Freed L.E., et al. Medium perfusion enables engineering of compact and contractile cardiac tissue. Am J Physiol Heart Circ Physiol 2004, 286:H507-H516.
9. Brown M., Iyer R., Radisic M. Pulsatile perfusion bioreactor for cardiac tissue engineering. Biotechnol Prog 2008, 24:907-920.
10. Fidkowski C., Kaazempur-Mofrad M.R., Borenstein J., Vacanti J.P., Langer R., Wang Y. Endothelialized microvasculature based on a biodegradable elastomer. Tissue Eng 2005, 11:302-309.
11. Radisic M., Park H., Chen F., Salazar-Lazzaro J.E., Wang Y., Dennis R., et al. Biomimetic approach to cardiac tissue engineering: oxygen carriers and channeled scaffolds. Tissue Eng 2006, 12:2077-2091.
12. Madden L.R., Mortisen D.J., Sussman E.M., Dupras S.K., Fugate J.A., Cuy J.L., et al. Proangiogenic scaffolds as functional templates for cardiac tissue engineering. Proc Natl Acad Sci U S A 2010, 107:15211-15216.
13. Morritt A.N., Bortolotto S.K., Dilley R.J., Han X., Kompa A.R., McCombe D., et al. Cardiac tissue engineering in an in vivo vascularized chamber. Circulation 2007, 115:353-360.
14. Jiang F., Zhang G., Hashimoto I., Kumar B.S., Bortolotto S., Morrison W.A., et al. Neovascularization in an arterio-venous loop-containing tissue engineering chamber: role of NADPH oxidase. J Cell Mol Med 2008, 12:2062-2072.
15. Zimmermann W.H., Melnychenko I., Wasmeier G., Didie M., Naito H., Nixdorff U., et al. Engineered heart tissue grafts improve systolic and diastolic function in infarcted rat hearts. Nat Med 2006, 12:452-458.
16. Takahashi H., Yokota T., Uchimura E., Miyagawa S., Ota T., Torikai K., et al. Newly developed tissue-engineered material for reconstruction of vascular wall without cell seeding. Ann Thorac Surg 2009, 88:1269-1276.
17. Ferrara N., Gerber H.P., LeCouter J. The biology of VEGF and its receptors. Nat Med 2003, 9:669-676.
18. Schroeder J.W., Rastatter J.C., Walner D.L. Effect of vascular endothelial growth factor on laryngeal wound healing in rabbits. Otolaryngol Head Neck Surg 2007, 137:465-470.
19. Lee K.Y., Peters M.C., Anderson K.W., Mooney D.J. Controlled growth factor release from synthetic extracellular matrices. Nature 2000, 408:998-1000.
20. Tabata Y., Miyao M., Ozeki M., Ikada Y. Controlled release of vascular endothelial growth factor by use of collagen hydrogels. J Biomater Sci Polym Ed 2000, 11:915-930.
21. Hao X., Silva E.A., Mansson-Broberg A., Grinnemo K.H., Siddiqui A.J., Dellgren G., et al. Angiogenic effects of sequential release of VEGF-A165 and PDGF-BB with alginate hydrogels after myocardial infarction. Cardiovasc Res 2007, 75:178-185.
22. Steffens G.C., Yao C., Prevel P., Markowicz M., Schenck P., Noah E.M., et al. Modulation of angiogenic potential of collagen matrices by covalent incorporation of heparin and loading with vascular endothelial growth factor. Tissue Eng 2004, 10:1502-1509.
23. Dvir T., Kedem A., Ruvinov E., Levy O., Freeman I., Landa N., et al. Prevascularization of cardiac patch on the omentum improves its therapeutic outcome. Proc Natl Acad Sci U S A 2009, 106:14990-14995.
24. Fan V.H., Tamama K., Au A., Littrell R., Richardson L.B., Wright J.W., et al. Tethered epidermal growth factor provides a survival advantage to mesenchymal stem cells. Stem Cells 2007, 25:1241-1251.
25. Chiu L.L., Radisic M. Scaffolds with covalently immobilized VEGF and angiopoietin-1 for vascularization of engineered tissues. Biomaterials 2010, 31:226-241.
26. Wu J., Sun Z., Sun H.S., Weisel R.D., Keating A., Li Z.H., et al. Intravenously administered bone marrow cells migrate to damaged brain tissue and improve neural function in ischemic rats. Cell Transplant 2008, 16:993-1005.
27. Ozawa T., Mickle D.A., Weisel R.D., Koyama N., Wong H., Ozawa S., et al. Histologic changes of nonbiodegradable and biodegradable biomaterials used to repair right ventricular heart defects in rats. J Thorac Cardiovasc Surg 2002, 124:1157-1164.
28. Li R.K., Jia Z.Q., Weisel R.D., Merante F., Mickle D.A. Smooth muscle cell transplantation into myocardial scar tissue improves heart function. J Mol Cell Cardiol 1999, 31:513-522.
29. Jain R.K., Au P., Tam J., Duda D.G., Fukumura D. Engineering vascularized tissue. Nat Biotechnol 2005, 23:821-823.
30. Laflamme M.A., Murry C.E. Regenerating the heart. Nat Biotechnol 2005, 23:845-856.
31. Menasche P. Skeletal myoblast for cell therapy. Coron Artery Dis 2005, 16:105-110.
32. Shen Y.H., Shoichet M.S., Radisic M. Vascular endothelial growth factor immobilized in collagen scaffold promotes penetration and proliferation of endothelial cells. Acta Biomater 2008, 4:477-489.
33. Grabarek Z., Gergely J. Zero-length crosslinking procedure with the use of active esters. Anal Biochem 1990, 185:131-135.
34. Chiu L.L., Weisel R.D., Li R.K., Radisic M. Defining conditions for covalent immobilization of angiogenic growth factors onto scaffolds for tissue engineering. J Tissue Eng Regen Med 2010.
35. Kutryk M.J., Stewart D.J. Angiogenesis of the heart. Microsc Res Tech 2003, 60:138-158.
36. Garin G., Mathews M., Berk B.C. Tissue-resident bone marrow-derived progenitor cells: key players in hypoxia-induced angiogenesis. Circ Res 2005, 97:955-957.
37. Fazel S., Chen L., Weisel R.D., Angoulvant D., Seneviratne C., Fazel A., et al. Cell transplantation preserves cardiac function after infarction by infarct stabilization: augmentation by stem cell factor. J Thorac Cardiovasc Surg 2005, 130:1310.
38. Tomita S., Mickle D.A., Weisel R.D., Jia Z.Q., Tumiati L.C., Allidina Y., et al. Improved heart function with myogenesis and angiogenesis after autologous porcine bone marrow stromal cell transplantation. J Thorac Cardiovasc Surg 2002, 123:1132-1140.
39. Shimizu T., Sekine H., Yang J., Isoi Y., Yamato M., Kikuchi A., et al. Polysurgery of cell sheet grafts overcomes diffusion limits to produce thick, vascularized myocardial tissues. FASEB J 2006, 20:708-710.
40. Liu J., Sluijter J.P., Goumans M.J., Smits A.M., van der Spoel T., Nathoe H., et al. Cell therapy for myocardial regeneration. Curr Mol Med 2009, 9:287-298.
41. Shimizu T., Sekine H., Yamato M., Okano T. Cell sheet-based myocardial tissue engineering: new hope for damaged heart rescue. Curr Pharm Des 2009, 15:2807-2814.